- Neuralstem Rounding Second With Phase II ALS Trial
- Biotechnology: Strong Fundamentals Are The Basis Of Strong Performance
- Survival Strategies For Development Biotechs And How They Affect Share Prices
- Phase II Trials Will Be Pivotal For These Stem Cell Companies
- 4 Drug Delivery Companies That Deliver For Investors
Ryan's View
Ryan's View
Stop FollowingRyan's View
ABOUT
I am a retired economist living in the Big Apple. I worked as a trader in many positions over the past decade as well. I am interested in IT, biotech, Pharma and telecom.
SNAPSHOT
- Description: Retiree. Trading frequency: Daily
- Interests: Energy stocks, Stocks - long, Stocks - short, Tech stocks
COMPANY
Currently, there is no company profile for Ryan's View.
BLOG
Currently, there are no blog details for Ryan's View.
Book
Currently, there are no book details for Ryan's View.
Latest Comments
more »
- Solars, if you want short t... on Survival Strategies For Development Biotechs An...
- Hey Doc - Thanks for the co... on Survival Strategies For Development Biotechs An...
- bioinvestor711 - I can only... on Phase II Trials Will Be Pivotal For These Stem ...
- Brian - What's your take on... on 2 Regenerative Medicine Plays For 2013
- vreteno - That is of course... on 4 Companies Ringing The Bell
Latest comments on Ryan's's Articles
- JMY Investments on Neuralstem Rounding Second With Phase II ALS Trial
- arose126 on Neuralstem Rounding Second With Phase II ALS Trial
- skywola on Neuralstem Rounding Second With Phase II ALS Trial
- vallies on Biotechnology: Strong Fundamentals Are The Basi...
- tomfalbo on Biotechnology: Strong Fundamentals Are The Basi...
LATEST ARTICLES & INSTAPOSTS
more »
